These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37975869)

  • 21. Pain and dermal reaction caused by injected glycerin in immunotherapy solutions.
    Van Metre TE; Rosenberg GL; Vaswani SK; Ziegler SR; Adkinson NF
    J Allergy Clin Immunol; 1996 May; 97(5):1033-9. PubMed ID: 8626978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Common neuroimmunological features of drug addiction, alcoholism, epilepsy, and neurogenic pain syndromes].
    Evseev VA; Davydova TV; Vetrilé LA; Trekova NA; Fomina VG
    Vestn Ross Akad Med Nauk; 2006; (7):38-43. PubMed ID: 16924877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoptive immunotherapy of cancer: accomplishments and prospects.
    Rosenberg SA
    Cancer Treat Rep; 1984 Jan; 68(1):233-55. PubMed ID: 6362866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic thoracic radiculopathy: a case of a young woman with clinical improvement following immunotherapy.
    Taiello AC; La Bella V; Spataro R
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33310829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer immunotherapy: STINGing systemically.
    Villanueva MT
    Nat Rev Drug Discov; 2018 Dec; 18(1):15. PubMed ID: 30591729
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific immunotherapy for allergic rhinitis in children.
    Wang C; Zhang L
    Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):487-94. PubMed ID: 25207858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study.
    Papa S; Adami A; Metoudi M; Beatson R; George MS; Achkova D; Williams E; Arif S; Reid F; Elstad M; Beckley-Hoelscher N; Douri A; Delord M; Lyne M; Shivapatham D; Fisher C; Hope A; Gooljar S; Mitra A; Gomm L; Morton C; Henley-Smith R; Thavaraj S; Santambrogio A; Andoniadou C; Allen S; Gibson V; Cook GJR; Parente-Pereira AC; Davies DM; Farzaneh F; Schurich A; Guerrero-Urbano T; Jeannon JP; Spicer J; Maher J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37321663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary.
    Mei J; Wang H; Fan H; Ding J; Xu J
    Front Immunol; 2022; 13():900119. PubMed ID: 35812375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy options for painful bladder syndrome: what's the potential?
    Mykoniatis I; Katafigiotis I; Sfoungaristos S; Yutkin V
    Expert Opin Biol Ther; 2017 Dec; 17(12):1471-1480. PubMed ID: 28874100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG.
    Meeusen JW; Lennon VA; Klein CJ
    Neurology; 2012 Oct; 79(17):1824-5. PubMed ID: 23054232
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe chronic nonlichenoid oral mucositis in pembrolizumab-treated patients: new cases and a review of the literature.
    Amy DPB; Shalabi A; Finfter O; Birenzweig Y; Zadik Y
    Immunotherapy; 2020 Aug; 12(11):777-784. PubMed ID: 32611271
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapy for Gastroesophageal Tumors: Is there still Hope for Efficacy?
    Puhr HC; Ilhan-Mutlu A
    Curr Cancer Drug Targets; 2022 Aug; 22(8):651-666. PubMed ID: 35060452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for scorpion envenoming in Brazil.
    Rezende NA; Amaral CF; Freire-Maia L
    Toxicon; 1998 Nov; 36(11):1507-13. PubMed ID: 9792165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy in the treatment of advanced prostate cancer.
    Djavan B; Nelson K; Kazzazi A; Bruhn A; Sadri H; Gomez-Pinillos A; Ferrari AC
    Can J Urol; 2011 Oct; 18(5):5865-74. PubMed ID: 22018147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis.
    Laukhtina E; Mori K; Mostafaei H; Merseburger AS; Nyirady P; Moschini M; Quhal F; Schuettfort VM; Pradere B; Motlagh RS; Enikeev D; Shariat SF; Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group EA
    Immunotherapy; 2021 Aug; 13(11):917-929. PubMed ID: 34078134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging findings can't mean everything in the era of immunotherapy: a case report and literature review.
    Zhao X; Ma K; Ma X; Wang X; Sun C; Qiu S; Guo Y; Yang Z; Liu Y; Xu Y
    Immunotherapy; 2024 Feb; 16(2):99-106. PubMed ID: 38112042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The past, present, and future of immunotherapy for endometrial adenocarcinoma.
    Jones AC; Brown KH; Guan T; Smith LA; Formslag CR; Farjado ED; Bai Q; Luechtefeld HD; Wakefield MR; Dong L; Fang Y
    Med Oncol; 2023 May; 40(7):186. PubMed ID: 37219649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum sickness triggered by anaphylaxis: a complication of immunotherapy.
    Umetsu DT; Hahn JS; Perez-Atayde AR; Geha RS
    J Allergy Clin Immunol; 1985 Nov; 76(5):713-8. PubMed ID: 4056255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal Analgesic Plan for Children Undergoing Chimeric 14.18 Immunotherapy.
    Bertolizio G; Otis A; Tam K; Aswar S; Garbin M; Ingelmo P
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e169-e172. PubMed ID: 31972721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.
    Zhang X; Wu X; Li D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.